| 000 | 01724 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250514064515.0 | ||
| 264 | 0 | _c20030529 | |
| 008 | 200305s 0 0 eng d | ||
| 022 | _a0017-9078 | ||
| 024 | 7 |
_a10.1097/00004032-200304000-00004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGonzalez, L | |
| 245 | 0 | 0 |
_aPatient surface radiation doses at two PET imaging facilities. _h[electronic resource] |
| 260 |
_bHealth physics _cApr 2003 |
||
| 300 |
_a451-6 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Evaluation Study; Journal Article; Validation Study | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBreast _xdiagnostic imaging |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorodeoxyglucose F18 _xpharmacokinetics |
| 650 | 0 | 4 |
_aGonads _xdiagnostic imaging |
| 650 | 0 | 4 |
_aHeart _xdiagnostic imaging |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver _xdiagnostic imaging |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMyocardium _xmetabolism |
| 650 | 0 | 4 | _aOrgan Specificity |
| 650 | 0 | 4 |
_aOvary _xmetabolism |
| 650 | 0 | 4 | _aRadiation Dosage |
| 650 | 0 | 4 |
_aRadiometry _xinstrumentation |
| 650 | 0 | 4 | _aRadionuclide Imaging |
| 650 | 0 | 4 | _aRadiopharmaceuticals |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 | _aSafety |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 |
_aSkin _xmetabolism |
| 650 | 0 | 4 |
_aThermoluminescent Dosimetry _xinstrumentation |
| 700 | 1 | _aCordeiro, C A | |
| 700 | 1 | _aVano, E | |
| 700 | 1 | _aPerez Castejon, M J | |
| 700 | 1 | _aJimenez, A | |
| 700 | 1 | _aMontz, H R | |
| 700 | 1 | _aDomper, M | |
| 700 | 1 | _aCarreras, J L | |
| 773 | 0 |
_tHealth physics _gvol. 84 _gno. 4 _gp. 451-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00004032-200304000-00004 _zAvailable from publisher's website |
| 999 |
_c12496905 _d12496905 |
||